BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2596 related articles for article (PubMed ID: 1146928)

  • 21. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
    Scott JZ; Kletzky OA; Brenner PF; Mishell DR
    Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM; Fauser BC
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy.
    Cortés-Gallegos V; Carranco A; Sojo I; Navarrette M; Cervantes C; Parra A
    Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS; Chapdelaine A; Upmalis D; Olson W; Smith J
    Acta Obstet Gynecol Scand Suppl; 1992; 156():9-14. PubMed ID: 1324557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of combined oral contraceptive steroids on the gonadotropin responses to LH-RH in lactating women with regular menstrual cycles resumed.
    Ryu K; Hong SS
    Contraception; 1983 Jun; 27(6):605-17. PubMed ID: 6413131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
    Grimes EM; Thompson IE; Taymor ME
    J Natl Med Assoc; 1983 Jun; 75(6):575-80. PubMed ID: 6410078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of oral contraceptives on integrated secretion of gonadotropins.
    Dericks-Tan JS; Gudacker V; Taubert HD
    Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency.
    Goldzieher JW; Pena A; Chenault CB; Woutersz TB
    Am J Obstet Gynecol; 1975 Jul; 122(5):619-24. PubMed ID: 1146927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioimmunoassay of unconjugated plasma ethynylestradiol in women given a single oral dose of ethynylestradiol or mestranol.
    de la Pena A; Chenault CB; Goldzieher JW
    Steroids; 1975 Jun; 25(6):773-80. PubMed ID: 1154455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invluence of oral contraceptives on circulating immune response. II. Effect of progestogenic and estrogenic components.
    Rangnekar KN; Rao SS; Joshi UM
    Contraception; 1974 Nov; 10(5):527-33. PubMed ID: 4141295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovulation inhibition following vaginal administration of pills containing norethindrone and mestranol.
    Coutinho EM; Silva AR; Carreira C; Barbosa I
    Contraception; 1984 Feb; 29(2):197-202. PubMed ID: 6723313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 130.